Search Within

Saad Zafar Usmani

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Meeting Abstract (81)
  2. Journal Article (19)
  3. Research Letter (4)
  4. Correspondence (1)
Groups
  1. Sloan Kettering Institute Postdocs (105)
  2. Department of Medicine (99)
  3. Graduate Medical Education (95)
  4. Center for Hematologic Malignancies (94)
  5. Hematologic Malignancies, Division of (94)
  6. Myeloma (94)

More Groups

People
  1. Malin Hultcrantz (91)
  2. Alexander Lesokhin (88)
  3. Sham Mailankody (88)
  4. Carlyn Rose Tan (87)
  5. Urvi Shah (87)
  6. Hani Hassoun (86)

More People

Years
  1. 2025 (4)
  2. 2024 (32)
  3. 2023 (42)
  4. 2022 (27)
Publications
  1. Clinical Lymphoma, Myeloma and Leukemia (37)
  2. Blood (35)
  3. Journal of Clinical Oncology (8)
  4. Blood Cancer Journal (7)
  5. Blood Advances (5)
  6. American Journal of Hematology (2)

More Publications

Publishers
  1. American Society of Hematology (40)
  2. Elsevier Inc. (39)
  3. American Society of Clinical Oncology (8)
  4. Nature Publishing Group (7)
  5. John Wiley & Sons, Inc. (2)
  6. Massachusetts Medical Society (2)

More Publishers

Results (105)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma
    Journal Article

    Firestone, R. S.; Socci, N. D.; Shekarkhand, T.; Zhu, M.; Qin, W. G.; Hultcrantz, M.; Mailankody, S.; Tan, C. R.; Korde, N.; Lesokhin, A. M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Patterns of CRS with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy
    Journal Article

    Hamadeh, I. S.; Shekarkhand, T.; Rueda, C.; Firestone, R. S.; Wang, A. X.; Korde, N.; Hultcrantz, M. L.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Comparison of infectious complications with BCMA-directed therapies in multiple myeloma
    Journal Article

    Nath, K.; Shekarkhand, T.; Nemirovsky, D.; Derkach, A.; Costa, B. A.; Nishimura, N.; Farzana, T.; Rueda, C.; Chung, D. J.; Landau, H. J.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma
    Journal Article

    Costa, B. A.; Flynn, J.; Nishimura, N.; Devlin, S. M.; Farzana, T.; Rajeeve, S.; Chung, D. J.; Landau, H. J.; Lahoud, O. B.; Scordo, M.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • CD8 effector T cells enhance teclistamab response in BCMA-exposed and -naìˆve multiple myeloma
    Journal Article

    Firestone, R. S.; McAvoy, D.; Shekarkhand, T.; Serrano, E.; Hamadeh, I.; Wang, A.; Zhu, M.; Qin, W. G.; Patel, D.; Tan, C. R.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups
    Journal Article

    Shah, U. A.; Moshier, E.; Derkach, A.; Huang, Y.; Mailankody, S.; Tan, C. R.; Maclachlan, K.; Hultcrantz, M.; Korde, N.; Hassoun, H.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Network modeling of apoptosis-related genes reveal a high-risk cluster in multiple myeloma
    Meeting Abstract

    Simhal, A. K.; Maclachlan, K. H.; Usmani, S. Z.; Norton, L.; Deasy, J. O.; Oh, J. H.; Tannenbaum, A.
    Blood (2023)

    Fulltext@MSK | Save
  • Recent patterns of radiotherapy use in multiple myeloma: Clinical outcomes and possible radiologic, biochemical, and genomic correlates of response
    Meeting Abstract

    Dreyfuss, A.; Fregonese, B.; Ma, J.; Sarkar, R. R.; Cederquist, G.; Usmani, S. Z.; Hajj, C.; Imber, B. S.; Yahalom, J.
    Blood (2023)

    Fulltext@MSK | Save
  • Daratumumab, bortezomib, lenalidomide, and dexamethasone (DVRd) and daratumumab, carfilzomib, lenalidomide and dexamethasone (DKRd) as induction therapy in newly diagnosed multiple myeloma
    Meeting Abstract

    Tan, C.; Maclachlan, K. H.; Nemirovsky, D.; Derkach, A.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; Patel, D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • T-cell exhaustion signature predicts early relapse after autologous stem cell transplant for multiple myeloma: BMT CTN 0702 secondary immune analysis
    Meeting Abstract

    Mehanna, N.; Derkach, A.; Gasmi, B.; Anagnostou, T.; Landau, H.; Lahoud, O. B.; Scordo, M.; Shah, G. L.; Hassoun, H.; Maclachlan, K. H.; more...
    Blood (2023)

    Fulltext@MSK | Save